Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan.

Name: Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan.
Author: Amano, Masayuki

Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan. — المؤلف: Amano, Masayuki — The Journal of infectious diseases 20221130

المؤلف: Amano, Masayuki
النشر: The Journal of infectious diseases 20221130
الوصف: 2038-2039 p.
الموضوعات: Humans؛ Japan؛ BNT162 Vaccine؛ SARS-CoV-2؛ COVID-19؛ Antibodies, Neutralizing؛ Antibodies, Viral؛ Vaccination